Phase 4
Completed N=40
Recovery Profile Comparison Between Remifentanil-propofol or Desflurane Anesthesia Monitored With Bispectral Index.
Delayed Emergence From Anesthesia
Source: ClinicalTrials.gov NCT02631525 ↗
Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Aug 2020
Primary outcomePrimary: Extubation Time — 9.5; 6.2 minutes
Summary
Bispectral monitoring anesthesia with remifentanil-desflurane has a better post-operative recovery than remifentanil-propofol.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Extubation Time |
9.5; 6.2 | — |
Eligibility Criteria
Inclusion Criteria
- Female patients over 18 years old classified by the American Society of Anesthesiologists as physical status I or II, undergoing elective breast surgery with general anesthesia.
Exclusion Criteria
- History of: illegal drug and alcohol abuse
- Pregnancy on course or suspicion of
- Neuromuscular disorders
- Cerebral vascular disease
- Dysphagia
- Dysphonia
- Gastroesophageal reflux disease
- Previous larynx and/or upper gastrointestinal tract surgery
- Allergy to any drug to be used and malignant hyperthermia.
- Patients who develop hemodynamic instability in the surgery and need blood transfusion were excluded from the study.
- Patients unable to swallow 20 ml of water in an upright position were also excluded.
Data sourced from ClinicalTrials.gov (NCT02631525). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.